CALCIUM LIQUID 100 MG / 5 ML — DIN 02245845
CALCIUM (CALCIUM GLUCONATE, CALCIUM LACTATE) : 100 MG / 5 ML · PHARMETICS (2011) INC · LIQUID · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is CALCIUM LIQUID?
CALCIUM LIQUID 100 MG / 5 ML contains CALCIUM (CALCIUM GLUCONATE, CALCIUM LACTATE) : 100 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02245845, held by PHARMETICS (2011) INC, supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Jul-2009. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Calcium (Different Salts In Combination) in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
15 holders have a Canadian DIN containing Calcium (Different Salts In Combination), across 20 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SANDOZ CANADA INC | 3 | 0 | CALCIUM SANDOZ FORTE 500MG, CALCIUM SANDOZ SYR, GRAMCAL EVT 1000MG | No marketed DIN |
| TROPICANA CANADA | 3 | 0 | TROPICANA CALCIUM SUPPLEMENT 344 MG, TROPICANA CALCIUM SUPPLEMENT 393 MG, TROPICANA CALCIUM SUPPLEMENT 604 MG | No marketed DIN |
| VITA HEALTH PRODUCTS INC | 2 | 0 | CALCIUM LIQUID, CALCIUM SYRUP 110MG/5ML | No marketed DIN |
| DISTRIBUTIONS MULTI-PRO INC. | 1 | 0 | CALCIUM TABLETS | No marketed DIN |
| KRIPPS PHARMACY LTD. | 1 | 0 | CALCIUM INJ | No marketed DIN |
| KSL PHARMACEUTICALS | 1 | 0 | CALCIUM LIQUID | No marketed DIN |
| NOVARTIS CONSUMER HEALTH CANADA INC. | 1 | 0 | CALCIUM SANDOZ SYR 110MG/5ML | No marketed DIN |
| PHARMETICS (2011) INC | 1 | 0 | CALCIUM LIQUID | No marketed DIN |
| SHOPPERS DRUG MART INC. | 1 | 0 | CALCIUM LIQUID | No marketed DIN |
| SUPPLEMENTS AROMATIK INC. | 1 | 0 | CALCIUM LIQUID SYRUP | No marketed DIN |
| THORNE RESEARCH INC. | 1 | 0 | CALCIUM CITRAMATE | No marketed DIN |
| WAMPOLE BRANDS, A DIVISION OF PANGEO PHARMA (CANADA) INC. | 1 | 0 | LIQUID CALCIUM | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG / 5 ML |
|---|---|
| Dosage form | LIQUID |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Calcium (Different Salts In Combination) |
|---|---|
| ATC code | A12AA20 |
| AHFS class | 88:29.00* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02245845 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2245845 |
| Brand name | CALCIUM LIQUID |
| Generic / active ingredient | CALCIUM (CALCIUM GLUCONATE, CALCIUM LACTATE) : 100 MG / 5 ML |
| Market authorization holder | PHARMETICS (2011) INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A12AA20 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A12AA |
| Current status | CANCELLED POST MARKET |
| Status date | 30-Jul-2009 |
| Original market date | 2002-09-30 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Calcium (Different Salts In Combination) in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by PFIZER CANADA ULC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 20 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| CALCIUM 500MG | 500 MG | TABLET | WN PHARMACEUTICALS LTD. | CANCELLED POST MARKET | 02240977 |
| CALCIUM 650MG TAB | 650 MG | TABLET | JAMIESON LABORATORIES LTD | CANCELLED POST MARKET | 02040913 |
| CALCIUM CITRAMATE | 160.0 MG | CAPSULE | THORNE RESEARCH INC. | CANCELLED POST MARKET | 02080222 |
| CALCIUM INJ | 10 MG | LIQUID | KRIPPS PHARMACY LTD. | DORMANT | 00532762 |
| CALCIUM LIQUID | 132 MG | LIQUID | KSL PHARMACEUTICALS | CANCELLED POST MARKET | 01904469 |
| CALCIUM LIQUID | 112 MG | LIQUID | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | 00508640 |
| CALCIUM LIQUID | 132 MG | LIQUID | SHOPPERS DRUG MART INC. | CANCELLED POST MARKET | 00548154 |
| CALCIUM LIQUID SYRUP | 100 MG / 5 ML | SYRUP | SUPPLEMENTS AROMATIK INC. | CANCELLED POST MARKET | 02246675 |
| CALCIUM SANDOZ FORTE 500MG | 2.94 G | TABLET (EFFERVESCENT) | SANDOZ CANADA INC | CANCELLED POST MARKET | 00027588 |
| CALCIUM SANDOZ SYR | 531.5 MG / 5 ML | SYRUP | SANDOZ CANADA INC | CANCELLED POST MARKET | 00027383 |
2 · Same class — other molecules in ATC A12AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Calcium Carbonate | CAL SUPP 500 · CAL SUPP 500 - TAB · CALCITE 500 TAB · CALCIUM · +32 more | 39 | 0 | Not in Canada |
| Calcium (Different Salts In Combination) | CALCIUM 500MG · CALCIUM 650MG TAB · CALCIUM CITRAMATE · CALCIUM INJ · +13 more | 20 | 0 | Not in Canada |
| Calcium Gluconate | CALCIUM GLUCONATE 10% INJ 100MG/ML · CALCIUM GLUCONATE INJ 10% · CALCIUM GLUCONATE INJ 100MG/ML · CALCIUM GLUCONATE INJ USP 10% · +8 more | 16 | 0 | Not in Canada |
| Calcium Lactate | CALCIMAX TAB 324MG · CALCIUM LACTATE 650MG · CALCIUM LACTATE TAB 10GR · CALCIUM LACTATE TAB 324MG · +7 more | 14 | 0 | Not in Canada |
| Calcium | BIOCALTH CALCIUM POWDER · BIOCALTH CALCIUM SUPPLEMENT · BODYSMARTS WITH CALCIUM · CAL-CITRUS · +8 more | 13 | 0 | Not in Canada |
| Calcium Phosphate | CAL GEL CAP 45MG · GELLUCAL CAP 45MG | 2 | 0 | Not in Canada |
| Calcium Chloride | CALCIUM CHLORIDE INJ 10% · CALCIUM CHLORIDE INJECTION 100MG/ML | 2 | 0 | Not in Canada |
| Calcium Glucoheptonate | CALCIUM LIQ ALSI · SIROP DE CALCIUM 625MG/5ML | 2 | 0 | Not in Canada |
| Calcium Citrate Lysine Complex | SOLUBLE CALCIUM CITRATE 1200MG | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A12A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A12AX | Calcium, Combinations With Vitamin D And/Or Other Drugs | 152 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.